title: A hemodialysis patient with higher-risk myelodysplastic syndrome treated with standard-dose azacitidine.
authors.forename: Johanna C
authors.initials: JC
authors.lastname: Ham
authors.forename: Judith M
authors.initials: JM
authors.lastname: Hoogendijk-van den Akker
authors.forename: Leo F
authors.initials: LF
authors.lastname: Verdonck
mesh_terms: D000368:Aged; D001374:Azacitidine / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008780:Methyltransferases / Q000037:antagonists & inhibitors; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy*; D007690:Polycystic Kidney Diseases / Q000150:complications / Q000628:therapy; D006435:Renal Dialysis; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors; D008780:Methyltransferases; D001374:Azacitidine